A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Bipolar Disorder
Interventions
DRUG

Aripiprazole

Tablets, Oral, 5 - 30 mg, Once daily, 8 weeks.

DRUG

Placebo

Tablets, Oral, 0 mg, Once daily, 8 weeks.

Trial Locations (8)

Unknown

Local Institution, Durham

Local Institution, Ahmedabad

Local Institution, Chennai

Local Institution, Delhi

Local Institution, Hyderabad

Local Institution, Lucknow

Local Institution, Mumbai

Local Institution, Visakhapatnam

Sponsors
All Listed Sponsors
collaborator

Otsuka America Pharmaceutical

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT00338273 - A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode | Biotech Hunter | Biotech Hunter